Furthermore, FACS-isolated CD133+ GBM cells gave rise to larger intracranial tumors compared to their CD133- counterparts, when injected in equal numbers (15,000 cells/animal) into NOD.SCID mice (S4D Fig.). The gene discussed is PROM1; the disease is glioblastoma.